Reply by authors to "Handling of commercially available enzyme immunoassays for 8-iso-prostaplandin F-2 alpha (8-iso-PGF(2 alpha),ipf(2 alpha)-III, 15-F-2t-IsoP) in clinical research and science: consideration from the analytical and review point of view"